ABOUT THE EVENT

    The pharmaceutical industry has played a leading role in the global response to the Covid-19 pandemic. In the urgent search for a vaccine, pharma companies have innovated and collaborated to dramatically accelerate processes that historically take an average 10-15 years. Within just 12 months of the WHO declaring COVID-19 a pandemic, we now have four vaccines approved for use and being rapidly rolled out across the UK.

    Data analytics and AI are playing a major role in the disruption of a wide range of pharmaceutical processes, from drug discovery to trials, regulation and production. Data is also opening up transformational new business models such as personalised medicine, that could drive pharma companies to position themselves much closer to the patient or consumer.

    In this panel session we explored:

    • How are pharma companies using data analytics and AI to disrupt the industry?
    • How will the COVID-19 pandemic change the pharma industry?
    • What is the future of the pharma industry and what role will data and AI play?

    AS PART OF

    DCF

    SPEAKERS

    Rasmus Hogreffe – Vice President of Decentralized Clinical Trial Innovation, Medable

    Rasmus Hogreffe – Vice President of Decentralized Clinical Trial Innovation, Medable

    Rasmus, MSc.Med., MBA is considered as a Decentralized Clinical Trial Expert. He is the VP of Decentralized Clinical Trial Innovation at Medable. Before joining Medable he was the head of Virtual Clinical Trials at LEO Innovation Lab.

    His main goal is to improve treatment for patients by making trials better and faster than ever before, using digital and remote innovations.

    Christopher Smith – Associate Director, Global Analytics and Insights, Gilead Sciences

    Christopher Smith – Associate Director, Global Analytics and Insights, Gilead Sciences

    Christopher is an experienced manager with a demonstrated history of working globally in the pharmaceuticals and biotech industry. Skilled in forecasting, market research, business development, competitive intelligence, and advanced data analytics.

    Tom Mellor – Client Principal, Health, Social Care & Pharma, BJSS

    Tom Mellor – Client Principal, Health, Social Care & Pharma, BJSS

    Tom is part of BJSS’ health, social care and pharmaceuticals leadership team. He has over 10 years’ experience across engineering, technology and management consulting supporting clients to deliver a wide range of complex transformation projects.

    Carl Austin – UK CTO, BJSS

    Carl Austin – UK CTO, BJSS

    Carl is UK CTO at BJSS. He has a natural passion for all things technology, a specialism in data and distributed systems and a small(ish) but unique shoe collection.

    SEE WHAT WE’VE BEEN UP TO

    Latest News
    Like what you’ve seen?

    GET IN TOUCH WITH US

    Please complete this short form and we’ll get in touch to discuss your needs. By submitting this form you confirm that you have read the BJSS Privacy Notice

    DOWNLOAD THE CONTENT

    Please complete this short form and we’ll email you a link to access your content. By submitting this form you confirm that you have read the BJSS Privacy Notice.

    EXPANDING
    POSSIBILITIES

    princess-awards-2021-logo-white
       © 2024 BJSS Limited. Registered in England with company number 2777575 VAT Number GB613295452. ‘Enterprise Agile®’ and ‘BJSS Enterprise Agile®’ are registered trademarks of BJSS Limited.